These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6308312)

  • 1. Antigenicity of HLA-D locus antigens in human cell-mediated lympholysis.
    Ohsawa N; Akiyama N
    Jpn J Exp Med; 1983 Feb; 53(1):65-8. PubMed ID: 6308312
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of HLA antigen disparity on CML reactivity.
    Dohi K; Ono E; Fukuda Y; Asahara T; Yahata H; Ezaki H
    Hiroshima J Med Sci; 1984 Sep; 33(3):503-6. PubMed ID: 6334675
    [No Abstract]   [Full Text] [Related]  

  • 3. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA serology--1983.
    Grumet FC
    Prog Clin Biol Res; 1984; 149():207-20. PubMed ID: 6204338
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-mediated lympholysis: target susceptibility to lysis correlates with surface major histocompatibility complex expression.
    Suranyi MG; Waugh J; Bishop GA; Hall BM
    Transplant Proc; 1987 Feb; 19(1 Pt 1):417-20. PubMed ID: 2950620
    [No Abstract]   [Full Text] [Related]  

  • 6. Functional cell mediated lympholysis: II. Genetics.
    Goeken NE; Thompson JS
    Tissue Antigens; 1981; 17(4):411-20. PubMed ID: 6949337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL) as stimulating cells in mixed lymphocyte culture (MLC).
    Wasik M; Matej H; Duś D; Myc A
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):879-85. PubMed ID: 6331341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of macrophages in T lymphocyte response to Candida allergen in man with special reference to HLA-D and DR.
    Nose Y; Komori K; Inouye H; Nomura K; Yamamura M; Tsuji K
    Clin Exp Immunol; 1981 Jul; 45(1):152-7. PubMed ID: 7030536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class II antigens and the human thyroid cell: a review.
    Davies TF; Piccinini LA
    Mt Sinai J Med; 1986 Jan; 53(1):23-30. PubMed ID: 3512982
    [No Abstract]   [Full Text] [Related]  

  • 10. HLA and bone marrow transplantation.
    Bach FH
    Prog Clin Biol Res; 1984; 149():257-70. PubMed ID: 6204340
    [No Abstract]   [Full Text] [Related]  

  • 11. Target susceptibility in cell-mediated lympholysis assays correlates with major histocompatibility complex surface antigen expression.
    Suranyi MG; Bishop GA; Waugh J; Hall BM
    Transplant Proc; 1987 Apr; 19(2):2869-72. PubMed ID: 3551229
    [No Abstract]   [Full Text] [Related]  

  • 12. Isolation and characterization of monoclonal mouse cytotoxic T lymphocytes with specificity for HLA-A,B or -DR alloantigens.
    Engelhard VH; Benjamin C
    J Immunol; 1982 Dec; 129(6):2621-9. PubMed ID: 6982933
    [No Abstract]   [Full Text] [Related]  

  • 13. A functional assay of HLA-directed non-T-cell mediated lympholysis (CML).
    Goeken NE; Thompson JS
    Transplant Proc; 1978 Dec; 10(4):943-6. PubMed ID: 153620
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody-dependent cell-mediated cytotoxicity against HLA-A, HLA-B and HLA-DR specificities.
    Akiyama N; Ohsawa N; Kano K
    Int Arch Allergy Appl Immunol; 1984; 74(3):286-8. PubMed ID: 6327536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of unrelated HLA-identical bone marrow donors: RFLP, oligotyping and PCR fingerprinting for HLA class II compared to MLC responses.
    Mazzola G; el-Borai MH; Berrino M; Cornaglia M; Amoroso A
    Bone Marrow Transplant; 1993; 11 Suppl 1():24-7. PubMed ID: 8095414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MLC compatibility, HLA-D and DR typing in cadaver kidney transplantations.
    Thomsen M; Morling N; Ladefoged J; Løkkegård H; Jakobsen B; Svejgaard A; Thaysen JH
    Scand J Urol Nephrol Suppl; 1980; 54():32-5. PubMed ID: 6452681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The HLA histocompatibility system].
    Wadgymar A
    Rev Invest Clin; 1984; 36(3):287-92. PubMed ID: 6393263
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell-mediated lympholysis in man: identification of a common target determinant associated with HLA-B12 and Bw35.
    Schendel DJ; Wank R; Hansen JA; Dupont B
    Transplant Proc; 1977 Dec; 9(4):1777-80. PubMed ID: 74883
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of HLA class I and II on peripheral blood lymphocytes in HBV infection.
    Wang CX; Wang JF; Liu M; Zou X; Yu XP; Yang XJ; Zheng GX
    Chin Med J (Engl); 2006 May; 119(9):753-6. PubMed ID: 16701016
    [No Abstract]   [Full Text] [Related]  

  • 20. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I.
    Süsal C; Opelz G
    Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.